Author:
Gamage Deepa G,Read Tim RH,Bradshaw Catriona S,Hocking Jane S,Howley Kerry,Chen Marcus Y,Fairley Christopher K
Abstract
Abstract
Background
We aimed to determine the incidence of Hepatitis C (HCV) infection among HIV-infected men who have sex with men (MSM) attending a Sexual Health Centre.
Methods
A retrospective cohort study was carried out among HIV-infected MSM seen at least once between February 2002 and March 2010. The analysis was restricted to MSM who had had a negative HCV antibody test at least 6 months after their diagnosis for HIV. Duration of follow up was taken from the date of HIV diagnosis to the first positive or last negative HCV antibody test.
Results
During the time 1445 HIV-infected men attended the clinic of whom 1065 (74%) were MSM. Of these, 869 (82%) were tested for HCV at any time after HIV diagnosis. Of these 869, 69% (620) tested HCV negative at least 6 months after their HIV diagnosis. These 620 men had a mean age of 34 years (range 17-72) at HIV diagnosis and a total of 4,359 person years (PY) of follow up. There were 40 incident cases of HCV, of which 16 were in injecting drug users (IDU) and 24 in non-IDU. The overall incidence of HCV among HIV-infected MSM was 0.9/100 PY (95% CI 0.6-1.2). The incidence among HIV-infected IDU was 4.7/100 PY (95% CI 2.7-7.5) while the incidence among HIV-infected non-IDU was 0.6/100 PY (95% CI 0.4-0.8) (hazard ratio of 8.7 and 95% CI 4.6-16.6, P < 0.001).
The majority (78%) were tested for HCV because they developed abnormal liver transaminases (n = 31) or hepatitis symptoms (n = 2), while others (n = 7) were identified through routine HCV testing.
Conclusion
A considerable proportion of HIV-positive MSM who did not inject drugs contracted HCV, presumably via sexual transmission and the main trigger for investigation was abnormal liver transaminases.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Joseph J, Stoff DM, van der Horst C: HIV/hepatitis C virus co-infection: basic, behavioral and clinical research in mental health and drug abuse. AIDS. 2005, 19 (suppl 3): S3-S7. 10.1097/01.aids.0000192063.01658.48.
2. David L, Thomas MD: HIV/HCV co infection: comorbidity and clinical implications. Adv Stud Med. 2005, 5 (4C): S352-5.
3. National Centre in HIV Epidemiology and Clinical Research (NCHECR) (2009): Annual Surveillance Report HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia[online]. 2009, cited 29/06/2010, [http://www.nchecr.unsw.edu.au/NCHECRweb.nsf/resources/SurvReports_3/$file/ASR2009-updated-2.pdf]
4. Salmon-Ceron D, Lewden C, Morlat P, Bevilacqua S, Jougla E, Bonnet F, et al: Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005, 42 (6): 799-805. 10.1016/j.jhep.2005.01.022.
5. Alter MJ: Prevention of spread of hepatitis C. Hepatology. 2002, 36 (5 Suppl 1): S93-8. 10.1002/hep.1840360712.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献